Related Experiment Video
Updated: Jun 27, 2025

09:56
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
498
Global research trends in CAR-T cell therapy for solid tumors: A comprehensive visualization and bibliometric study
Lele Miao1, Juan Zhang2, Wei Xu1
1Department of Thyroid and Breast Surgery, Jining NO.1 People's Hospital, Jining, China.
Human Vaccines & Immunotherapeutics
|May 3, 2024
Summary
Chimeric antigen receptor (CAR)-T cell therapy shows promise for solid tumors, with rapid research growth. The United States leads this field, with key institutions and researchers driving advancements in CAR-T cell treatments.
Area of Science:
- Oncology
- Immunotherapy
- Biotechnology
Background:
- CAR-T cell therapy is a significant approach for hematological malignancies.
- Its application in solid tumors is a rapidly growing area of research and clinical investigation.
Purpose of the Study:
- To conduct a bibliometric and knowledge map analysis of CAR-T cell therapy for solid tumors.
- To identify research trends, leading institutions, key authors, and emerging themes in this field.
Main Methods:
- Bibliometric analysis of publications retrieved from the Web of Science Core Collection (WoSCC).
- Knowledge map analysis to visualize research landscapes and collaborations.
Main Results:
- The field is experiencing rapid advancement, indicated by an increasing publication rate.
- The United States is the leading country, with the University of Pennsylvania as the most active institution.
- Carl H. June and Shannon L. Maude are identified as highly cited and co-cited authors, respectively; five main research hotspots and 10 emerging themes were identified.
Conclusions:
- CAR-T cell therapy for solid tumors is a dynamic and expanding research domain.
- Bibliometric analysis provides a comprehensive overview of the field's current status and future directions.
- Findings offer valuable insights for future research and development in CAR-T cell treatments for solid tumors.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Tumor Immunotherapy
520
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

